These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2234694)

  • 1. Technetium-99m antimony sulphide colloid lymphoscintigraphy of the prostate by direct transrectal injection.
    Zuckier LS; Finkelstein M; Kreutzer ER; Stone PL; Freed SZ; Bard RH; Blaufox MD; Freeman LM
    Nucl Med Commun; 1990 Sep; 11(9):589-96. PubMed ID: 2234694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radionuclide lymphoscintigraphy with technetium 99m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head and neck and trunk.
    Wanebo HJ; Harpole D; Teates CD
    Cancer; 1985 Mar; 55(6):1403-13. PubMed ID: 3971311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human prostatic lymphoscintigraphy. A preliminary report.
    Gardiner RA; Fitzpatrick JM; Constable AR; Cranage RW; O'Donoghue EP; Wickham JE
    Br J Urol; 1979 Aug; 51(4):300-3. PubMed ID: 466007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary lymphoscintigraphy in breast cancer.
    Uren RF; Howman-Giles RB; Thompson JF; Malouf D; Ramsey-Stewart G; Niesche FW; Renwick SB
    J Nucl Med; 1995 Oct; 36(10):1775-80. PubMed ID: 7562041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic sentinel lymph node versus hyperextensive pelvic dissection for staging clinically localized prostate carcinoma: a prospective study of 200 patients.
    Rousseau C; Rousseau T; Campion L; Lacoste J; Aillet G; Potiron E; Lacombe M; Le Coguic G; Mathieu C; Kraeber-Bodéré F
    J Nucl Med; 2014 May; 55(5):753-8. PubMed ID: 24686781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A direct comparison between subcutaneous and intralymphatic injections for lymphoscintigraphy.
    Gibson CJ; Vijayasimhulu GT; Diffey BL
    Clin Radiol; 1984 Jan; 35(1):81-3. PubMed ID: 6690187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visualization of canine and human prostatic lymph nodes following intraprostatic injection of technetium-99m-antimony sulfide colloid.
    Kaplan WD; Whitmore WF; Gittes RF
    Invest Radiol; 1980; 15(1):34-8. PubMed ID: 7353941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostatic lymphoscintigraphy.
    Stone AR; Merrick MV; Chisholm GD
    Br J Urol; 1979 Dec; 51(6):556-60. PubMed ID: 534841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iliopelvic lymphoscintigraphy as a predictor of early metastatic disease in patients with prostate carcinoma.
    Ferrier D; Kloiber R
    Clin Nucl Med; 1992 May; 17(5):357-60. PubMed ID: 1587039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High colloidal uptake in axillary nodes with metastatic disease.
    Peyton JW; Crosbie J; Bell TK; Roy AD; Odling-Smee W
    Br J Surg; 1981 Jul; 68(7):507-9. PubMed ID: 7248724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphatic drainage in prostate carcinoma assessed by lymphoscintigraphy and SPECT/CT: its importance for the sentinel node procedure.
    de Bonilla-Damiá A; Roberto Brouwer O; Meinhardt W; Valdés-Olmos RA
    Rev Esp Med Nucl Imagen Mol; 2012; 31(2):66-70. PubMed ID: 22055110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical comparison of two radiocolloids for internal mammary lymphoscintigraphy.
    Kaplan WD; Piez CW; Gelman RS; Laffin SM; Rosenbaum EM; Jennings CA; McCormick CA; Harris JR; Henderson IC; Atkins HL
    J Nucl Med; 1985 Dec; 26(12):1382-5. PubMed ID: 4067640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoscintigraphy in the staging of solid tumors.
    Osborne MP; Meijer WS; Yeh SD; DeCosse JJ
    Surg Gynecol Obstet; 1983 Mar; 156(3):384-91. PubMed ID: 6298959
    [No Abstract]   [Full Text] [Related]  

  • 14. Preoperative cutaneous lymphoscintigraphy in malignant melanoma.
    Lock-Andersen J; Rossing N; Drzewiecki KT
    Cancer; 1989 Jan; 63(1):77-82. PubMed ID: 2910428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The place of lymphoscintigraphy in the treatment of malignant melanoma of the skin (author's transl)].
    Munz DL; Altmeyer P; Holzmann H; Encke A; Hör G
    Dtsch Med Wochenschr; 1982 Jan; 107(3):86-91. PubMed ID: 7056162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetry in lymphoscintigraphy of Tc-99m antimony sulfide colloid.
    Bergqvist L; Strand SE; Persson B; Hafström L; Jönsson PE
    J Nucl Med; 1982 Aug; 23(8):698-705. PubMed ID: 7108614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of pelvic lymphoscintigraphy in the staging of colorectal carcinoma.
    Reasbeck PG; Manktelow A; McArthur AM; Packer SG; Berkeley BB
    Br J Surg; 1984 Dec; 71(12):936-40. PubMed ID: 6208965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of Tc-99m sestamibi for sentinel node mapping in breast carcinomas: comparison with Tc-99m antimony sulphide colloid.
    Sadeghi R; Zakavi SR; Forghani MN; Aryana K; Kakhki VR; Ayati NK; Shandiz FH; Ghavamnasiri MR; Keshtgar M
    Nucl Med Rev Cent East Eur; 2010; 13(1):1-4. PubMed ID: 21154308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of axillary lymphoscintigraphy in breast carcinoma patients.
    McLean RG; Ege GN
    J Nucl Med; 1986 Jul; 27(7):1116-24. PubMed ID: 3723187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.
    De Cicco C; Cremonesi M; Luini A; Bartolomei M; Grana C; Prisco G; Galimberti V; Calza P; Viale G; Veronesi U; Paganelli G
    J Nucl Med; 1998 Dec; 39(12):2080-4. PubMed ID: 9867145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.